FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics
FibroBiologics, Inc., a clinical-stage biotech company listed on Nasdaq under ticker FBLG, announced the filing of a provisional patent application with the USPTO for an innovative oral administration platform designed to deliver fibroblast-based therapeutics directly to the gastrointestinal tract. This delivery system aims to protect biologic acti…